Genotype 2
Showing 1 - 25 of >10,000
Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)
Recruiting
- Acute Coronary Syndrome
- CYP2C19 Polymorphism
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Hospital
Jun 27, 2023
Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)
Recruiting
- Hepatitis C, Chronic
- P1101 + Ribavirin
-
Chiayi City, Taiwan
- +7 more
Jun 30, 2022
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- (no location specified)
Oct 22, 2023
Drug-Drug Interaction Trial in Indianapolis (Methadone and Tizanidine, Efavirenz, Methadone and Tizanidine)
Not yet recruiting
- Drug-Drug Interaction
- Methadone and Tizanidine
- Efavirenz, Methadone and Tizanidine
-
Indianapolis, IndianaZeruesenay Desta
Mar 28, 2023
Impact of CES1 Genotype on Remimazolam
Not yet recruiting
- American Society of Anesthesiologists (ASA) Class 1-2
- +3 more
- Remimazolam besylate
- (no location specified)
Apr 24, 2023
Fuchs' Corneal Endothelial Dystrophy in France
Not yet recruiting
- Corneal Dystrophies
- Genotyping
- +2 more
-
Saint-Étienne, FranceCentre Hospitalier de Saint-Etienne
Feb 22, 2023
Stroke Trial in Laval (Cardiovascular training, Standard Therapy)
Recruiting
- Stroke
- Cardiovascular training
- Standard Therapy
-
Laval, Quebec, CanadaJewish Rehabiliation Hospital
Nov 17, 2022
Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)
Not yet recruiting
- Ischemic Stroke
- Transient Ischemic Attack
- Genetic testing
-
Singapore, SingaporeSingapore General Hospital
Mar 9, 2023
Phenotype, Genotype and Biomarkers 2
Recruiting
- Amyotrophic Lateral Sclerosis
- +4 more
-
Miami, Florida
- +3 more
Dec 19, 2022
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- ABT-493/ABT-530
- +2 more
- (no location specified)
Jul 14, 2021
Healthy Lifestyle, Taste Disorders, Diet Habit Trial in Poznan (Intervention genotype personalized nutritional recommendations,
Completed
- Healthy Lifestyle
- +2 more
- Intervention genotype personalized nutritional recommendations
- +2 more
-
Poznań, PolandPoznan University of Life Sciences
Jul 7, 2022
Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)
Completed
- Chronic Hepatitis C Virus (HCV) Infection
- ABT-493/ABT-530
- Placebo for ABT-493/ABT-530
- (no location specified)
Jul 14, 2021
CYP1A2 Polymorphism Trial in Poznan (Intervention group with genotype information, Control group without genotype information)
Completed
- CYP1A2 Polymorphism
- Intervention group with genotype information
- Control group without genotype information
-
Poznań, PolandPoznan University of Life Sciences
Feb 17, 2022
Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- CYP2C19 genotype guided P2Y12 monotherapy
- Clopidogrel
- (no location specified)
Mar 7, 2023
Hepatocellular Carcinoma Trial in Taoyuan (ADI-PEG20)
Recruiting
- Hepatocellular Carcinoma
-
Taoyuan, TaiwanChang Gung Memorial Hospital, Linkou branch
Sep 6, 2023
Angelman Syndrome Trial (60 mg QD Alogabat, 40 mg QD Alogabat, 7 mg QD Alogabat)
Not yet recruiting
- Angelman Syndrome
- 60 mg QD Alogabat
- +4 more
- (no location specified)
Feb 1, 2023
Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)
Completed
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients
Recruiting
- Covid19
- oropharyngeal and intestinal microbiota
- +3 more
-
Paris, FranceLESCURE
Jun 20, 2022
Peripheral Arterial Disease Trial in Netherlands (Direct CYP2C19 genotyping, CYP2C19 genotyping at the end of the study, Poor
Recruiting
- Peripheral Arterial Disease
- Direct CYP2C19 genotyping
- +4 more
-
Apeldoorn, Netherlands
- +10 more
Apr 19, 2022
Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))
Advanced Solid Tumors Trial in Belgium, Germany, Spain (Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR)
Recruiting
- Advanced Solid Tumors
- Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
-
Ghent, Belgium
- +2 more
Jun 23, 2022
Human Milk Oligosaccharides and FUT2 Polymorphism of Mothers in
Recruiting
- Breastfeeding, Exclusive
-
Jakarta Pusat, DKI Jakarta, IndonesiaBunda Jakarta Woman and Children Hospital
Dec 15, 2021